1. Most Discussed
  2. Gainers & Losers
MBP 3.0¢

shares mag top ten pick for 2003

  1. Latest SHARES Magazine is recommending MBP/MBPO among its top ten stock picks for the year.

    Extract from article:
    "Why choose Metabolic as the biotech stock of 2003? Metabolic will be conducting its pivotal Phase IIb trial for its anti-obesity drug AOD9604. It's a crucial step for Metabolic, and if successful, the company will be deservedly catapulted into a powerful bargaining position with potential pharmaceutical licensing partners."

    Link to full article:
    http://www.sharesmag.com.au/stories2/20030201/17600.asp

    I have been following Metabolic for years and timing and patience has paid off. They recently concluded the latest human trials and the results are due next month, so it's time to get on board before the results are released.

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top